The Most Advanced Conference to Modernize Clinical Research
The 14th Annual DPHARM® offered an unparalleled opportunity to hear senior clinical operations executives and innovative thought leaders unveil the latest innovations on modernizing clinical trials.
DPHARM faculty challenge the clinical operations community to rethink how clinical research gets done to drive greater inclusivity and value for patients.
Convening 800+ Attendees
DPHARM 2024 featured senior clinical operation executives with industry and patient thought leadership, and technologists showcasing the latest innovations in clinical trials driving efficiencies in operational processes and reducing patient, site and physician obstacles to participating in research.
2024 Keynote All-Star Lineup
Leadership & Risk
Management
Ambassador Sully Sullenberger
Captain of US Airways Flight 1549
Miracle on the Hudson
Patient
Experience
Sarah Zenner-Dolan
Former Pharma Exec
Turned Patient Advocate
ROI for
DCT Deployments
Kenneth Getz, MBA
Executive Director & Professor
Tufts CSDD, Tufts University School of Medicine
AI
Zeitgeist
Faisal Khan, PhD
Corporate Vice President,
AI and Analytics
Novo Nordisk
Creating Change with
the "What If" Mindset
Mike Rayburn
Award-Winning Speaker, Entertainer, and Guitar Virtuoso
"What If" Mindset
Senior Clinical Operations Leadership
Bari Kowal
SVP and Head, Development Operations, Portfolio Management and Biostatistics Data Management
Regeneron
Christoph Koenen, MD, MBA,
Head of Clinical Development and Operations, Pharmaceuticals R&D
Bayer
Melanie Ivarsson, OBE, PhD, MBA
SVP, Chief Development Officer
Moderna
Andy Lee,
SVP, Head, Global Clinical Trials Operations
Merck
Siân Ratcliffe, PhD
SVP, Head of Quantitative Sciences and Development Operations
Biogen
Deirdre BeVard
SVP, R&D Strategic Operations
CSL
Angela DeLuca, MBA, PMP
AVP, Head of Global Study Operations
Amgen
Candice Fitzgerald
Global Head Clinical Development and Operations Regions
Boehringer Ingelheim
Rosemary Rebuli
Global Head, Study and Site Operations, Global Clinical Trials
Novartis
Penny Carlson
VP, Head of Global Clinical Development Operations, Global Development Office, Research & Development
Takeda
Patient Disruptors
Emily Epstein
Patient Advocate
Yvonne Florence
Patient Advocate
Patrick Gee Sr, PhD, JLC
Patient Advocate, Founder & Chief Executive Hope Dealer
iAdvocate, Inc
Sabina Kineen
Patient Advocate
Barry Nelson
Patient Advocate
Karen Peterson
Founder & Chief Patient Advocate,
Karen’s Club
AI and GenAI Trailblazers
Syed Haider, PhD
Head of eClinical Business Intelligent Automation and Life Data Sciences
Merck
David Apfel
Head, External Innovation, R&D Data Science and Digital Health
Johnson & Johnson
Shameer Khader, PhD, MPH
Global Head, Computational Biology Cluster Precision Medicine & Computational Biology, R&D
Sanofi
Henry Wei, MD
Head of Development Innovation
Regeneron
DPHARM Idol Disrupt
DPHARM Idol Disrupt is a series of quick-fire presentations where you see bold and daring startups pitch their disruptive technologies to the most discerning judges. The Q&A provides amazing shared learnings on how to properly assess new technologies.
Congratulations to 2024 Winner, Power!
If you are interested in applying for a spot as a DPHARM Idol Disrupt 2025 presenter, email Meredith@tcfllc.org
DPHARM Commitment
- DPHARM combines TED-style talks with fireside chats, quick fires, panels and demos presentations showcasing innovations from leading Pharma R&D practitioners and from other industries.
- DPHARM underscores the promise and challenge of innovation in advancing drug development.
- DPHARM features new models and collaborations to get therapeutics to patients faster.
- DPHARM features the full spectrum of clinical research options and utilizes insights more appropriately.
- DPHARM is dedicated to challenging creative solutions and finding a way to implement them.